Organs-on-chips: into the next decade

LA Low, C Mummery, BR Berridge, CP Austin… - Nature Reviews Drug …, 2021 - nature.com
Abstract Organs-on-chips (OoCs), also known as microphysiological systems or 'tissue
chips'(the terms are synonymous), have attracted substantial interest in recent years owing …

Brain organoids: advances, applications and challenges

X Qian, H Song, G Ming - Development, 2019 - journals.biologists.com
Brain organoids are self-assembled three-dimensional aggregates generated from
pluripotent stem cells with cell types and cytoarchitectures that resemble the embryonic …

Shell microelectrode arrays (MEAs) for brain organoids

Q Huang, B Tang, JC Romero, Y Yang, SK Elsayed… - Science …, 2022 - science.org
Brain organoids are important models for mimicking some three-dimensional (3D)
cytoarchitectural and functional aspects of the brain. Multielectrode arrays (MEAs) that …

Induction of myelinating oligodendrocytes in human cortical spheroids

M Madhavan, ZS Nevin, HE Shick, E Garrison… - Nature …, 2018 - nature.com
Cerebral organoids provide an accessible system for investigations of cellular composition,
interactions, and organization but have lacked oligodendrocytes, the myelinating glia of the …

Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease models

E Taoufik, G Kouroupi, O Zygogianni… - Open …, 2018 - royalsocietypublishing.org
Synaptic dysfunction in CNS disorders is the outcome of perturbations in physiological
synapse structure and function, and can be either the cause or the consequence in specific …

A flexible 3-dimensional microelectrode array for in vitro brain models

DA Soscia, D Lam, AC Tooker, HA Enright, M Triplett… - Lab on a Chip, 2020 - pubs.rsc.org
Three-dimensional (3D) in vitro models have become increasingly popular as systems to
study cell–cell and cell–ECM interactions dependent on the spatial, mechanical, and …

An FDA/CDER perspective on nonclinical testing strategies: Classical toxicology approaches and new approach methodologies (NAMs)

AM Avila, I Bebenek, JA Bonzo, T Bourcier… - Regulatory Toxicology …, 2020 - Elsevier
Nonclinical testing of human pharmaceuticals is conducted to assess the safety of
compounds to be studied in human clinical trials and for marketing of new drugs. Although …

Modeling HIV-1 neuropathogenesis using three-dimensional human brain organoids (hBORGs) with HIV-1 infected microglia

RS Dos Reis, S Sant, H Keeney, MCE Wagner… - Scientific reports, 2020 - nature.com
HIV-1 associated neurocognitive disorder (HAND) is characterized by neuroinflammation
and glial activation that, together with the release of viral proteins, trigger a pathogenic …

[HTML][HTML] Recommendation on test readiness criteria for new approach methods (NAM) in toxicology: exemplified for developmental neurotoxicity (DNT)

A Bal-Price, HT Hogberg, KM Crofton, M Daneshian… - Altex, 2018 - ncbi.nlm.nih.gov
Multiple non-animal-based test methods have never been formally validated. In order to use
such new approach methods (NAMs) in a regulatory context, criteria to define their …

Gene–environment interactions in developmental neurotoxicity: a case study of synergy between chlorpyrifos and CHD8 knockout in human brainspheres

S Modafferi, X Zhong, A Kleensang… - Environmental …, 2021 - ehp.niehs.nih.gov
Background: Autism spectrum disorder (ASD) is a major public health concern caused by
complex genetic and environmental components. Mechanisms of gene–environment (G× E) …